Purchase Order 75N95025P00441

Award Date 9/29/25
Potential Completion Date 9/28/28
Potential Value $8.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
Total Small Business
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Labor Hours
Place of Performance
San Marcos, CA 92069, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
10
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price purchase order contract awarded by the Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse to the sole proprietorship Araldi Gian Luca for $130,000.00. The contract has a period of performance from August 1, 2019 to August 4, 2024 and is not set aside. Araldi Gian Luca, a total small business, will provide scientific research and development services to support neuroscience drug discovery and development programs...
This is a $532,500.00 purchase order contract for medicinal chemistry consulting services awarded by the National Institute of Neurological Disorders and Stroke (NINDS), a civilian agency under the National Institutes of Health (NIH), to a small business vendor named Araldi Gian Luca. The contract was set aside for total small businesses and has a period of performance through July 26, 2025. Araldi Gian Luca will provide technical guidance, collaboration, and management oversight on...
This federal contract award is for medicinal chemistry and bioactivity assay development consulting services provided by Araldi Gian Luca, a sole proprietorship small business, to the National Institute of Neurological Disorders and Stroke (NINDS), which is part of the National Institutes of Health (NIH). The 5-year, $21,150 contract was awarded on September 29, 2025 and is set aside for total small businesses. Araldi Gian Luca will provide technical guidance, collaboration, and management...
The U.S. National Institute on Drug Abuse (NIDA), a civilian agency within the Department of Health and Human Services, awarded a $10,000.00 labor-hour purchase order contract to Christoph Kahl, a small business located in Thousand Oaks, California. The contract is for pharmaceutics formulation and chemistry manufacturing and controls (CMC) consulting services to support NIDA's drug discovery and development programs, including the NIH Blueprint Neurotherapeutics, Help End Addiction Longterm...
The National Institute on Drug Abuse (NIDA), part of the Department of Health and Human Services, awarded a $54,000.00 labor-hour purchase order contract to RPK Associates, LLC, a small business, for pharmaceutics formulation and chemistry manufacturing and controls (CMC) consulting services for small molecules and/or biologics. The contract has a base period from September 20, 2025, through September 19, 2026, with optional hours up to 800 total hours per consultant annually. The services...
This purchase order contract valued at $568,500 was awarded by the National Institutes of Health's National Institute of Neurological Disorders and Stroke to Dr. Gian Luca Araldi as the prime contractor. The contract is for process chemistry consulting services to support the NIH Blueprint Neurotherapeutics Network and NIH Helping to End Addiction Long-term Initiative programs. Dr. Araldi will provide technical guidance and support as the key personnel consultant over a three-year period...
The National Institute of Neurological Disorders and Stroke (NINDS) awarded a $568,500.00 purchase order contract to Araldi Gian Luca, a sole proprietorship providing scientific research and development services. This contract is for pharmaceutics formulation/chemistry manufacturing and control consulting services for small molecules and/or biologics in support of the NINDS's neuroscience drug discovery and development programs, including the National Institutes of Health's (NIH) Blueprint...
This federal contract award was issued by the National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services (HHS). The contract was awarded to JP Lawson Consulting, a small business, to provide process chemistry consultant services to support the NIH Blueprint Neurotherapeutics Network (BPN) drug discovery and development programs. The contract is a Labor Hours Purchase Order with a ceiling value of...
This is a $487,200 labor-hour purchase order awarded by the National Institute of Neurological Disorders and Stroke (NINDS), part of the National Institutes of Health (NIH), to Araldi Gian Luca, a total small business. The contract provides process chemistry consultant support services to the NINDS Blueprint Neurotherapeutics Network (BPN), which funds neuroscience researchers and provides industry-style drug development services. The consultant will serve on BPN Lead Development Teams to...
The U.S. National Institute on Drug Abuse (NIDA), part of the Department of Health and Human Services' National Institutes of Health, awarded a $19,600.00 Purchase Order contract to Lin Jiunn, a small business located in Ambler, Pennsylvania. The contract is for a Subject Matter Expert Consultant in Drug Metabolism Pharmacokinetics (DMPK) to support NIDA's NIH Blueprint Neurotherapeutics Network program. The contract has a one-year base period with an estimated minimum of 20 annual hours and a...

This federal contract award is for pharmaceutical formulation, chemistry manufacturing, and controls (CMC) consulting services for small molecules and/or biologics, provided by a sole proprietor, Araldi Gian Luca, to the National Institute on Drug Abuse (NIDA), which is part of the U.S. Department of Health and Human Services. The contract is a labor-hour purchase order with a ceiling value of $8,460 and a total small business set-aside. It has a base period from September 20, 2025, through September 19, 2026, with optional hours up to 800 total hours per consultant annually. The services will support NIDA's drug discovery and development programs, including the NIH Blueprint Neurotherapeutics, Help End Addiction Longterm (HEAL), and the NIH Biologics program. The contract was awarded on September 29, 2025, and the ultimate completion date is September 28, 2028.

Generated 9/25/25, 10:55 AM